STABL Share Price Performance
SEK 0.20
-0.19 (-48.69%)
Price SEK 0.20
Share Pricen/a
Stayble Therapeutics AB (publ) Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
STABL Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
No trending discussion available.
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Stayble Therapeutics AB (publ) Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
- -0.17
- 100.00%
- 63,211.76%
- 0%
About STABL
- Founded
- 2015
- Employees
- 2
- CEO
- WebsiteView website
Stayble Therapeutics AB (publ) a clinical pharmaceutical company, developing an injection-based treatments for disc herniation. It develops STA363, an injection into the disc that targets chronic low back and leg pain. The company was incorporated in 2015 and is based in Gothenburg, Sweden.
